Oncotelic Therapeutics's total assets for Q1 2025 were $26.67M, a decrease of -0.03% from the previous quarter. OTLC total liabilities were $19.48M for the fiscal quarter, a 1.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.